BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 16120818)

  • 1. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
    Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-dependent podocyte failure causes glomerulosclerosis.
    Fukuda A; Chowdhury MA; Venkatareddy MP; Wang SQ; Nishizono R; Suzuki T; Wickman LT; Wiggins JE; Muchayi T; Fingar D; Shedden KA; Inoki K; Wiggins RC
    J Am Soc Nephrol; 2012 Aug; 23(8):1351-63. PubMed ID: 22773827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet.
    Wiggins JE; Goyal M; Wharram BL; Wiggins RC
    J Am Soc Nephrol; 2006 May; 17(5):1382-7. PubMed ID: 16597684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
    Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
    Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
    Wanke R; Wolf E; Brem G; Hermanns W
    Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
    Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
    Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
    Amann K; Nichols C; Tornig J; Schwarz U; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.
    Nishizono R; Kikuchi M; Wang SQ; Chowdhury M; Nair V; Hartman J; Fukuda A; Wickman L; Hodgin JB; Bitzer M; Naik A; Wiggins J; Kretzler M; Wiggins RC
    J Am Soc Nephrol; 2017 Oct; 28(10):2931-2945. PubMed ID: 28720684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.
    Hodgin JB; Bitzer M; Wickman L; Afshinnia F; Wang SQ; O'Connor C; Yang Y; Meadowbrooke C; Chowdhury M; Kikuchi M; Wiggins JE; Wiggins RC
    J Am Soc Nephrol; 2015 Dec; 26(12):3162-78. PubMed ID: 26038526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
    Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R
    Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.
    Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J
    J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.
    Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats.
    Ijpelaar DH; Schulz A; Koop K; Schlesener M; Bruijn JA; Kerjaschki D; Kreutz R; de Heer E
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F758-67. PubMed ID: 18199599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.
    Zhang J; Hansen KM; Pippin JW; Chang AM; Taniguchi Y; Krofft RD; Pickering SG; Liu ZH; Abrass CK; Shankland SJ
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F571-80. PubMed ID: 22129965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.